Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Carroll TM"'
Autor:
Al Moussawi, K, Chung, K, Carroll, TM, Osterburg, C, Smirnov, A, Lotz, R, Miller, P, Dedeić, Z, Zhong, S, Oti, M, Kouwenhoven, EN, Asher, R, Goldin, R, Tellier, M, Murphy, S, Zhou, H, Dötsch, V, Lu, X
Publikováno v:
Cell Reports, 41, 3, pp. 1-28
Cell Reports, 41, 1-28
Cell Reports, 41, 1-28
Concurrent mutation of a RAS oncogene and the tumor suppressor p53 is common in tumorigenesis, and inflammation can promote RAS-driven tumorigenesis without the need to mutate p53. Here, we show, using a well-established mutant RAS and an inflammatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8be9fc25e494c45f5112c6ec80f3c91
https://repository.ubn.ru.nl/handle/2066/285319
https://repository.ubn.ru.nl/handle/2066/285319
Autor:
Carroll TM; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Chadwick JA; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Owen RP; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., White MJ; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Kaplinsky J; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Peneva I; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK., Frangou A; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK., Xie PF; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Chang J; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Roth A; Department of Pathology and Molecular Medicine, University of British Columbia, Vancouver, Canada; Department of Computer Science, University of British Columbia, Vancouver, Canada; Department of Molecular Oncology, BC Cancer, Vancouver, Canada., Amess B; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., James SA; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Rei M; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Fuchs HS; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., McCann KJ; Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Omiyale AO; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Jacobs BA; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Lord SR; Department of Oncology, University of Oxford, Oxford, UK., Norris-Bulpitt S; Early Phase Clinical Trials Unit, Cancer & Haematology Centre, Churchill Hospital, Oxford, UK., Dobbie ST; Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, UK., Griffiths L; Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, UK., Ramirez KA; Ludwig Cancer Research, New York, NY, USA., Ricciardi T; Ludwig Cancer Research, New York, NY, USA., Macri MJ; Ludwig Cancer Research, New York, NY, USA., Ryan A; Ludwig Cancer Research, New York, NY, USA., Venhaus RR; Ludwig Cancer Research, New York, NY, USA., Van den Eynde BJ; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK; Ludwig Institute for Cancer Research, Brussels, Belgium; de Duve Institute, Université Catholique de Louvain, Brussels, Belgium., Karydis I; Cancer Sciences Unit, University of Southampton and Cancer Care Group, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Schuster-Böckler B; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK., Middleton MR; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK; Early Phase Clinical Trials Unit, Cancer & Haematology Centre, Churchill Hospital, Oxford, UK. Electronic address: mark.middleton@oncology.ox.ac.uk., Lu X; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK. Electronic address: xin.lu@ludwig.ox.ac.uk.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Jul 10; Vol. 41 (7), pp. 1222-1241.e7.
Autor:
Miller P; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK. paul.miller@ludwig.ox.ac.uk., Akama-Garren EH; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Owen RP; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Demetriou C; Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK., Carroll TM; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Slee E; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Al Moussawi K; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Ellis M; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Goldin R; Centre for Pathology, Department of Medicine, Imperial College London, London, W2 1NY, UK., O'Neill E; Centre for Pathology, Department of Medicine, Imperial College London, London, W2 1NY, UK., Lu X; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK. xin.lu@ludwig.ox.ac.uk.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2023 Jul; Vol. 30 (7), pp. 1619-1635. Date of Electronic Publication: 2023 Jun 03.
Autor:
Akama-Garren EH; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK. elliot_akama-garren@hms.harvard.edu.; Harvard-MIT Health Sciences and Technology, Harvard Medical School, Boston, MA, 02115, USA. elliot_akama-garren@hms.harvard.edu., Miller P; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Carroll TM; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Tellier M; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK., Sutendra G; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK.; Department of Medicine, University of Alberta, Edmonton, AB, T6G 2B7, Canada., Buti L; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK.; Charles River Laboratories, Leiden, Netherlands., Zaborowska J; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK., Goldin RD; Centre for Pathology, St. Mary's Hospital, Imperial College, London, W2 1NY, UK., Slee E; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Szele FG; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3PT, UK., Murphy S; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK., Lu X; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK. xin.lu@ludwig.ox.ac.uk.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 Feb 06; Vol. 14 (2), pp. 84. Date of Electronic Publication: 2023 Feb 06.
Autor:
Al Moussawi K; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Chung K; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Carroll TM; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Osterburg C; Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany., Smirnov A; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Lotz R; Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany., Miller P; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Dedeić Z; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Zhong S; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK., Oti M; Radboud University, Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Kouwenhoven EN; Radboud University, Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Asher R; Cellular Pathology, John Radcliffe Hospital, Oxford OX3 9DU, UK; Department of Histopathology, University Hospital Wales, Cardiff CF14 4XW, UK., Goldin R; Department of Pathology, Imperial College London, Faculty of Medicine at St Mary's, Norfolk Place, London W2 1PG, UK., Tellier M; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK., Murphy S; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK., Zhou H; Radboud University, Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands; Radboud University Medical Centre, Department of Human Genetics, Radboud Institute for Molecular Life Sciences, 6500 Nijmegen, the Netherlands., Dötsch V; Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany., Lu X; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, UK. Electronic address: xin.lu@ludwig.ox.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2022 Oct 18; Vol. 41 (3), pp. 111503.
Autor:
Hoekzema RS; Mathematical Institute, University of Oxford, Oxford OX1 2JD, UK.; Department of Mathematics, Free University of Amsterdam, 1081 HV Amsterdam, The Netherlands., Marsh L; Mathematical Institute, University of Oxford, Oxford OX1 2JD, UK.; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX1 2JD, UK., Sumray O; Mathematical Institute, University of Oxford, Oxford OX1 2JD, UK.; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX1 2JD, UK., Carroll TM; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX1 2JD, UK., Lu X; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX1 2JD, UK., Byrne HM; Mathematical Institute, University of Oxford, Oxford OX1 2JD, UK.; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX1 2JD, UK., Harrington HA; Mathematical Institute, University of Oxford, Oxford OX1 2JD, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford OX1 2JD, UK.
Publikováno v:
Entropy (Basel, Switzerland) [Entropy (Basel)] 2022 Aug 13; Vol. 24 (8). Date of Electronic Publication: 2022 Aug 13.
Autor:
Davison LM; Cleveland Clinic Foundation, Department of Immunology, Lerner Research Institute, Cleveland, OH, United States.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States., Liu JC; Cleveland Clinic Foundation, Department of Immunology, Lerner Research Institute, Cleveland, OH, United States., Huang L; Cancer Immunology, Inflammation and Tolerance Program, Georgia Cancer Center, Augusta University, Augusta, GA, United States., Carroll TM; Cleveland Clinic Foundation, Department of Immunology, Lerner Research Institute, Cleveland, OH, United States., Mellor AL; Cancer Immunology, Inflammation and Tolerance Program, Georgia Cancer Center, Augusta University, Augusta, GA, United States., Jørgensen TN; Cleveland Clinic Foundation, Department of Immunology, Lerner Research Institute, Cleveland, OH, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Aug 27; Vol. 10, pp. 2017. Date of Electronic Publication: 2019 Aug 27 (Print Publication: 2019).
Autor:
Ji, Gang1 (AUTHOR), Yang, Qi2 (AUTHOR), Wang, Song3 (AUTHOR), Yan, Xiaolong4 (AUTHOR), Ou, Qiuxiang3 (AUTHOR), Gong, Li5 (AUTHOR), Zhao, Jinbo4 (AUTHOR), Zhou, Yongan4 (AUTHOR), Tian, Feng4 (AUTHOR), Lei, Jie4 (AUTHOR), Mu, Xiaorong5 (AUTHOR), Wang, Jian4 (AUTHOR), Wang, Tao4 (AUTHOR), Wang, Xiaoping4 (AUTHOR), Sun, Jianyong4 (AUTHOR), Zhang, Jipeng4 (AUTHOR), Jia, Chenghui6 (AUTHOR), Jiang, Tao4 (AUTHOR) jiangtaochest@163.com, Zhao, Ming-gao2 (AUTHOR) minggao@fmmu.edu.cn, Lu, Qiang4 (AUTHOR) luqiang@fmmu.edu.cn
Publikováno v:
Genome Medicine. 4/2/2024, Vol. 16 Issue 1, p1-19. 19p.
Autor:
Carroll TM; Dermatology Branch, National Cancer Institute, Bethesda, Maryland, USA., Williams JS; Dermatology Branch, National Cancer Institute, Bethesda, Maryland, USA., Daily K; Dermatology Branch, National Cancer Institute, Bethesda, Maryland, USA., Rogers T; Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Gelb T; Dermatology Branch, National Cancer Institute, Bethesda, Maryland, USA., Coxon A; Dermatology Branch, National Cancer Institute, Bethesda, Maryland, USA., Wang SQ; Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Crago AM; Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Busam KJ; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Brownell I; Dermatology Branch, National Cancer Institute, Bethesda, Maryland, USA. Electronic address: isaac.brownell@nih.gov.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2017 May; Vol. 137 (5), pp. 1187-1190. Date of Electronic Publication: 2017 Jan 25.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.